| P2093 | author name string | Michel Rigaud | |
| | Guislaine Barrière | |
| | Michel Tartary | |
| | Alain Riouallon | |
| | Joël Renaudie | |
| P2860 | cites work | Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel | Q24298654 |
| | The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 |
| | ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome | Q24657877 |
| | Prospective identification of tumorigenic breast cancer cells | Q24683474 |
| | Akt2: a role in breast cancer metastasis | Q24803933 |
| | Epithelial-mesenchymal transitions in tumour progression | Q27860487 |
| | A perspective on cancer cell metastasis | Q28307891 |
| | Systemic spread is an early step in breast cancer | Q29617041 |
| | Generation of breast cancer stem cells through epithelial-mesenchymal transition | Q29619717 |
| | Phosphoinositide 3-kinase signalling pathways | Q33940898 |
| | Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study | Q33958866 |
| | Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. | Q35558093 |
| | Prognosis based on primary breast carcinoma instead of pathological nodal status | Q36079769 |
| | Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer | Q36934364 |
| | Epithelial-mesenchymal transition in breast cancer progression and metastasis | Q36986452 |
| | Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. | Q37090760 |
| | Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? | Q37219226 |
| | Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients | Q37360176 |
| | Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status | Q39648560 |
| | Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition | Q39659307 |
| | Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. | Q39822968 |
| | Parallel progression of primary tumours and metastases | Q45831582 |
| | Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer | Q73469713 |
| | The log likelihood ratio test (the G-test); methods and tables for tests of heterogeneity in contingency tables | Q74518220 |
| | Cancer stem cells and metastasis: lethal seeds | Q79188271 |
| | Circulating tumor cells: not all detected cells are bad and not all bad cells are detected | Q83663783 |
| | Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients | Q83985287 |
| | The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer | Q84078585 |
| | Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells | Q85060184 |
| | Tumorigenesis: Twist1 links EMT to self-renewal | Q85117478 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| | cancer diagnosis | Q110324059 |
| P304 | page(s) | 114 | |
| P577 | publication date | 2012-03-23 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis | |
| P478 | volume | 12 | |